Why choose Davlexx?
Davlexx is a company enthusiastic and excited in our innovative vision to eliminate drug resistant superbugs, using journal supported, evidence based research, as part of the global AMR research community of the future.
Our Story
The first preliminary test results for a DAVLEXX product was by MD-TEC, a European Regional Development Fund and was completed in 2018.
This nontoxic topical solution KILLED ALL THREE antibiotic resistant super-bugs.
MRSA
ACINETOBACTER
PSEUDOMONAS AERUGINOSA
100% effective and complete microbicidal action in 10 minutes.
CLICK IMAGE ABOVE TO INVEST IN DAVLEXX ⬆️⬆️